|Articles|September 25, 2014

Special Reports

  • Gynecologic Cancers (Issue 1)
  • Volume 1
  • Issue 1

Trabectedin as a Treatment Option for Patients with Ovarian Cancer

Bradley Monk, MD, gynecologic oncologist, University of Arizona Cancer Center Phoenix Branch, discusses trabectedin as a potential agent to treat ovarian cancer.

Bradley Monk, MD, gynecologic oncologist, University of Arizona Cancer Center Phoenix Branch, discusses trabectedin as a potential agent to treat ovarian cancer.

Read about research into ovarian cancer > >


Latest CME